Osteoporosis and sarcopenia: two diseases or one?

Jean-Yves Reginster, Charlotte Beaudart, Fanny Buckinx, Olivier Bruyère

Journal: Current opinion in clinical nutrition and metabolic care 2016;19(1):31-6

PMID: 26418824

Abstract

PURPOSE OF REVIEW

This article reviews recently published evidence for common pathways explaining bone and muscle wasting in normal ageing and pathological conditions.

RECENT FINDINGS

Numerous studies support the concept of a bone-muscle unit, where constant cross-talking between the two tissues takes place, involving molecules released by the skeletal muscle secretome, which affects bone, and osteokines secreted by the osteoblasts and osteocytes, which, in turn, impact muscle cells.

SUMMARY

New chemical entities aiming at concomitantly treating osteoporosis and sarcopenia could be developed by targeting pathways that centrally regulate bone and muscle or emerging pathways that facilitate the communication between the two tissues.

Address: aDepartment of Public Health, Epidemiology and Health Economics bSupport Unit in Epidemiology and Biostatistics, University of Liège, Liège, Belgium.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.